Agreement for psoriasis treatment

I reported previously (see here) on the small molecule treatments from Israel’s Can-Fite for psoriasis, liver and inflammatory diseases, and cancer. Can-Fite AND South Korea-based Kyongbo have just signed a distribution agreement for Can-Fite’s psoriasis treatment Piclidenoson (CF101).,7340,L-3767633,00.html

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *